Download PDF
Semin Respir Crit Care Med 2012; 33(02): 156-162
DOI: 10.1055/s-0032-1311794
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Triaging in Pulmonary Embolism

Olivier Sanchez
1   Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
2   Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
3   INSERM U765, Paris, France.
,
Benjamin Planquette
1   Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
2   Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
3   INSERM U765, Paris, France.
,
Antoine Roux
1   Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
2   Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
,
Marine Gosset-Woimant
1   Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
2   Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
,
Guy Meyer
1   Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
2   Assistance Publique Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs, Hôpital Européen Georges Pompidou, Paris, France.
3   INSERM U765, Paris, France.
› Author Affiliations
Further Information

Publication History

Publication Date:
30 May 2012 (online)

    Permissions and Reprints

Abstract

Risk stratification of patients with pulmonary embolism represents an important step and may help to guide initial therapeutic management. Pulmonary embolism can be stratified into several groups, with different risk of early death or complications based on the presence of several risk factors. High-risk pulmonary embolism is defined by shock or peripheral signs of hypoperfusion. It is a life-threatening emergency with high short-term mortality (>25%) requiring specific therapeutic strategy with inotropic agents and fibrinolysis. In normotensive patients with pulmonary embolism, the presence of right ventricular dysfunction assessed by echocardiography or myocardial injury based on elevated levels of biomarkers, is associated with an intermediate risk of early death. These patients require close monitoring, and the role of thrombolytic treatment is currently assessed in a large trial. Lastly, patients with normotensive pulmonary embolism and without right ventricular dysfunction or myocardial injury have a low risk of death and complications. These patients may be candidates for home treatment. Several scores combining these risk factors have been described.

Keywords

pulmonary embolism - risk stratification - predicting prognosis - right ventricular failure - troponin - brain natriuretic peptide (BNP)
 

  • References

  • 1 Torbicki A, Perrier A, Konstantinides S , et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29 (18) 2276-2315
    CrossrefPubMedGoogle Scholar
  • 2 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162) 1386-1389
    CrossrefPubMedGoogle Scholar
  • 3 Kasper W, Konstantinides S, Geibel A , et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997; 30 (5) 1165-1171
    CrossrefPubMedGoogle Scholar
  • 4 Otero R, Trujillo-Santos J, Cayuela A , et al; Registro Informatizado de la Enfermedad Tromboembólica (RIETE) Investigators. Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?. Eur Respir J 2007; 30 (6) 1111-1116
    CrossrefPubMedGoogle Scholar
  • 5 Aujesky D, Obrosky DS, Stone RA , et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172 (8) 1041-1046
    CrossrefPubMedGoogle Scholar
  • 6 Aujesky D, Roy PM, Le Manach CP , et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27 (4) 476-481
    CrossrefPubMedGoogle Scholar
  • 7 Donzé J, Le Gal G, Fine MJ , et al. Prospective validation of the Pulmonary Embolism Severity Index: a clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100 (5) 943-948
    PubMedGoogle Scholar
  • 8 Jiménez D, Yusen RD, Otero R , et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132 (1) 24-30
    CrossrefPubMedGoogle Scholar
  • 9 Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost 2010; 8 (7) 1509-1514
    CrossrefPubMedGoogle Scholar
  • 10 Jiménez D, Aujesky D, Moores L , et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170 (15) 1383-1389
    CrossrefPubMedGoogle Scholar
  • 11 Aujesky D, Roy PM, Guy M, Cornuz J, Sanchez O, Perrier A. Prognostic value of D-dimer in patients with pulmonary embolism. Thromb Haemost 2006; 96 (4) 478-482
    PubMedGoogle Scholar
  • 12 Klok FA, Djurabi RK, Nijkeuter M , et al. High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity. Br J Haematol 2008; 140 (2) 218-222
    PubMedGoogle Scholar
  • 13 Lobo JL, Zorrilla V, Aizpuru F , et al; RIETE Investigators. D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. J Thromb Haemost 2009; 7 (11) 1795-1801
    CrossrefPubMedGoogle Scholar
  • 14 Jiménez D, Aujesky D, Díaz G , et al; RIETE Investigators. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2010; 181 (9) 983-991
    CrossrefPubMedGoogle Scholar
  • 15 Frémont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 2008; 133 (2) 358-362
    CrossrefPubMedGoogle Scholar
  • 16 Sanchez O, Trinquart L, Colombet I , et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008; 29 (12) 1569-1577
    CrossrefPubMedGoogle Scholar
  • 17 Becattini C, Agnelli G, Vedovati MC , et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011; 32 (13) 1657-1663
    CrossrefPubMedGoogle Scholar
  • 18 van der Bijl N, Klok FA, Huisman MV , et al. Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome. Chest 2011; 140 (4) 1008-1015
    CrossrefPubMedGoogle Scholar
  • 19 Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178 (4) 425-430
    CrossrefPubMedGoogle Scholar
  • 20 Lega JC, Lacasse Y, Lakhal L, Provencher S. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis. Thorax 2009; 64 (10) 869-875
    CrossrefPubMedGoogle Scholar
  • 21 Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116 (4) 427-433
    CrossrefPubMedGoogle Scholar
  • 22 Jiménez D, Uresandi F, Otero R , et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. Chest 2009; 136 (4) 974-982
    CrossrefPubMedGoogle Scholar
  • 23 Jiménez D, Díaz G, Molina J , et al. Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism. Eur Respir J 2008; 31 (4) 847-853
    CrossrefPubMedGoogle Scholar
  • 24 Lankeit M, Friesen D, Aschoff J , et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 2010; 31 (15) 1836-1844
    CrossrefPubMedGoogle Scholar
  • 25 Sanchez O, Trinquart L, Caille V , et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 2010; 181 (2) 168-173
    CrossrefPubMedGoogle Scholar
  • 26 Stein PD, Matta F, Janjua M, Yaekoub AY, Jaweesh F, Alrifai A. Outcome in stable patients with acute pulmonary embolism who had right ventricular enlargement and/or elevated levels of troponin I. Am J Cardiol 2010; 106 (4) 558-563
    CrossrefPubMedGoogle Scholar
  • 27 Jiménez D, Aujesky D, Moores L , et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011; 66 (1) 75-81
    CrossrefPubMedGoogle Scholar
  • 28 Kaczyñska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 2006; 371 (1–2) 117-123
    CrossrefPubMedGoogle Scholar
  • 29 Puls M, Dellas C, Lankeit M , et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 2007; 28 (2) 224-229
    PubMedGoogle Scholar
  • 30 Dellas C, Puls M, Lankeit M , et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 2010; 55 (19) 2150-2157
    CrossrefPubMedGoogle Scholar
  • 31 Lankeit M, Kempf T, Dellas C , et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med 2008; 177 (9) 1018-1025
    CrossrefPubMedGoogle Scholar
  • 32 Aujesky D, Roy PM, Verschuren F , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011; 378 (9785) 41-48
    CrossrefPubMedGoogle Scholar